Page 1113 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

4 References

115. Saksida A, Duh D, Wraber B. Interacting roles of immune mech- 135. Fulhorst CF, Koster FT, Enria DA, et al. Hantavirus Infections.
anisms and viral load in the pathogenesis of Crimean-Congo In: Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious
hemorrhagic fever. Clin Vaccin Immunol. 2010;17:1086-1093. Diseases: Principles, Pathogens and Practice. 3rd ed. London:
116. Ergönül Ö. Treatment of Crimean-Congo hemorrhagic fever. Elsevier Health Sciences; 2011.
Antivir Res. 2008;78:125-131. 136. Rasmuson J, Andersson C, Norrman E, et al. Time to revise
117. Daubney R, Hudson JR, Garnham PC. Enzootic hepatitis or Rift the paradigm of hantavirus syndromes? Hantavirus pulmonary
Valley fever: an undescribed virus disease of sheep, cattle and syndrome caused by European hantavirus. Eur J Clin Microbiol
man from East Africa. J Pathol Bacteriol. 1931;34:545-579. Infect Dis. 2011;30:685-690.
118. Hightower A, Kinkade C, Nguku PM, et al. Relationship of 137. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary
climate, geography and geology to the incidence of Rift Valley syndrome: a clinical description of 17 patients with a newly
fever in Kenya during the 2006-2007 outbreak. Am J Trop Med recognized disease. N Engl J Med. 1994;330:949-955. Seminal
Hyg. 2012;86:373-380. article.
119. Peters CJ, Makino S, Morrill JC. Rift Valley fever. In: Guerrant 138. Khan AS, Khabbaz RF, Armstrong LR. Hantavirus pulmonary
RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases: syndrome: the first 100 US cases. J Inf Dis.1996;173:1297-1303.
Principles, Pathogens and Practice. 3rd ed. London: Elsevier Seminal article.
health sciences; 2011. 139. MacNeil A, Ksiazek TG, Rollin PE. Hantavirus pulmo-
120. Ikegami T, Makino S. The pathogenesis of Rift Valley fever. nary syndrome, United States, 1993–2009. Emerg Inf Dis.
Viruses. 2011;3:493-519. 2011;17(7):1195-1201. Seminal article.
121. Anyangu AS, Gould LH, Sharif SK. Risk factors for severe Rift 140. MacNeil A, Nichol ST, Spiropoulou CF. Hantavirus pulmonary
Valley fever infection in Kenya, 2007. Am J Trop Med Hyg. syndrome. Virus research. 2011;162:138-147.
2010;83(suppl 2):14-21. 141. Figueiredo LTM, Moreli ML, de Sousa RLM. Hantavirus pul-
122. Pepin M, Bouloy M, Bird B, et al. Rift Valley fever virus monary syndrome, central plateau, southeastern and southern
(Bunyaviridae: Phlebovirus): an update on pathogenesis, molec- Brazil. Emerg Infect Dis. 2009;15:561-567.
ular epidemiology, vectors, diagnostics and prevention. Vet Res. 142. Ye C, Prescott J, Nofchissey R, et al. Neutralizing antibodies and
2010;41:61-100. Sin Nombre virus RNA after recovery from hantavirus cardio-
123. Mundel B, Gear J. Rift Valley fever. I. The occurrence of human pulmonary syndrome. Emerg Infect Dis. 2004;10:478-482.
cases in Johannesburg. S Afr Med J. 1951;25:926-930. 143. Cruz CD, Forshey BM, Vallejo E, et al. Novel strain of Andes
124. Davies FG. The historical and recent impact of Rift Valley fever virus associated with fatal human infection, central Bolivia.
in Africa. Am J Trop Med Hyg. 2010;83(suppl 2):73-74. Emerg Inf Dis. 2012;18 (5):750-757.
125. Madani TA, Al-Mazrou YY, Al-Jeffri MH. Rift Valley fever epi- 144. Zhang YZ, Zou Y, Fu ZF. Hantavirus infections in humans and
demic in Saudi Arabia: epidemiological, clinical, and laboratory animals, China. Emerg Inf Dis. 2010;16(8):1195-1203.
characteristics. Clin Inf Dis. 2003;37:1084-1092. Seminal article. 145. Vapalahti O, Mustonen J, Lundkvist A. Hantavirus infections in
126. LaBeaud AD, Kazura JW, King CH. Advances in Rift Valley Europe. Lancet Inf Dis. 2003;3:653-661.
fever research: insights for disease prevention. Curr Opin Infect 146. Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent
Dis. 2010;23:403-408. of Korean hemorrhagic fever. J Inf Dis. 1978;137:298-308.
127. Alrajhi AA, Al-Semari A, Al-Watban J. Rift Valley fever enceph- 147. Lee HW, Baek LJ, Johnson KM. Isolation of Hantaan virus, the
alitis. Emerg Inf Dis. 2004;10:554-555. etiologic agent of Korean hemorrhagic fever from wild urban
128. Ikegami T, Makino S. Rift Valley fever vaccines. Vaccine. rats. J Inf Dis. 1982;146(5):638-644.
2009;27:D69-D72. 148. Lee HW, Bark DH, Baek, LJ, et al. Korean hemorrhagic fever
129. Yu XJ, Liang MF, Zhang SY, et al. Fever with thrombocytopenia patients in urban areas of Seoul. Korean J Virol. 1980;10:1-6.
associated with a novel Bunyavirus in China. N Engl J Med. 149. Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective,
2011;364:1523-1532. Seminal article. double-blind, concurrent, placebo-controlled clinical trial of
130. Zhang YZ, Zhou DJ, Qin XC. The ecology, genetic diversity, intravenous ribavirin therapy of hemorrhagic fever with renal
and phylogeny of Huaiyangshan virus in China. J Virol. 2012; syndrome. J Infect Dis. 1991;164:1119.
86:2864-2868. 150. Maes P, Clement J, Van Ranst M. Recent approaches in hantavi-
131. Bao C, Guo X, Hu J, et al. A family cluster of infections by a rus vaccine development. Expert Rev Vaccines. 2009;8(1):67-76.
newly recognized Bunyavirus in Eastern China, 2007: fur- 151. Fisher-Hoch SP, Tomori O, Nasidi A, et al. Review of cases of
ther evidence of person-to-person transmission. Clin Inf Dis. nosocomial Lassa fever in Nigeria: the high price of poor medi-
2011;53:1208-1214. cal practice. BMJ. 1995;311:857–859.
132. Liu Y, Li Q, Hu W, et al. Person-to-person transmission of severe 152. Center for Disease Control and Prevention. Management of
fever with thrombocytopenia syndrome virus. Vector Borne patients with suspected viral hemorrhagic fever. MMWR.
Zoonotic Dis. 2012;12:156-160. 1988;37(S-3):1-16.
133. Lázaro ME, Cantoni GE, Calanni LM, et al. Clusters of 153. Bausch DG, Hadi CM, Khan SH, et al. Review of the
Hantavirus Infection, Southern Argentina. Emerg Infect Dis. literature and proposed guidelines for the use of oral Ribavirin
2007;13:104-110. as postexposure prophylaxis for Lassa fever. Clin Inf Dis.
134. Jonsson CB, Figueiredo LTM, Vapalahti O. A global perspective 2010;51:1435-1441.
on Hantavirus ecology, epidemiology, and disease. Clin Microbiol
Rev. 2010;23:412-441. Seminal article.

Section05-O-ref.indd 4 1/20/2015 4:51:26 PM